Discovery of a Promising CBP/p300 Degrader XYD129 for the Treatment of Acute Myeloid Leukemia.
Wu T, Hu J, Zhao X, Zhang C, Dong R, Hu Q, Xu H, Shen H, Zhang X, Zhang Y, Lin B, Wu X, Xiang Q, Xu Y.
Wu T, et al. Among authors: hu j.
J Med Chem. 2024 Jun 3. doi: 10.1021/acs.jmedchem.4c00335. Online ahead of print.
J Med Chem. 2024.
PMID: 38829718